These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1963214)

  • 21. Stereoselective enhancement of nociception by opioids in different strains of mice.
    Ramabadran K
    Jpn J Pharmacol; 1985 Mar; 37(3):296-9. PubMed ID: 2987591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulatory activity of kappa-, mu-, and delta-selective opioid compounds.
    Rogers TJ; Taub DD; Eisenstein TK; Geller EB; Adler MW
    NIDA Res Monogr; 1990; 105():82-8. PubMed ID: 1652095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.
    Panerai AE; Martini A; Sacerdote P; Mantegazza P
    Brain Res; 1984 Jun; 304(1):153-6. PubMed ID: 6331578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels.
    Watkins LR; Wiertelak EP; Maier SF
    Brain Res; 1992 Jun; 582(1):1-9. PubMed ID: 1354010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of hyperthermia-induced convulsions in immature rat by MR-2266, a kappa antagonist.
    Laorden ML; Carrillo E; Puig MM
    Methods Find Exp Clin Pharmacol; 1991 Nov; 13(9):605-8. PubMed ID: 1686291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid antagonists and drinking: evidence of kappa-receptor involvement.
    Leander JD; Hynes MD
    Eur J Pharmacol; 1983 Mar; 87(4):481-4. PubMed ID: 6303802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
    Schmauss C; Yaksh TL
    J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration.
    Summy-Long JY; Rosella-Dampman LM; McLemore GL; Koehler E
    Neuroendocrinology; 1990 Apr; 51(4):376-84. PubMed ID: 1971712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of opiate antagonists on food intake are stereospecific.
    Sanger DJ; McCarthy PS; Metcalf G
    Neuropharmacology; 1981 Jan; 20(1):45-7. PubMed ID: 6261182
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of kappa-opioid receptor agonists on locomotor activity and memory processes in mice.
    Castellano C; Ammassari-Teule M; Libri V; Pavone F
    Pol J Pharmacol Pharm; 1988; 40(5):507-13. PubMed ID: 2855367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL; Mathiasen JR; Raffa RB
    J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL; Nayanar V; Walker JS
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of epsilon and kappa opioid receptors in inhibition of the tail-flick response induced by bremazocine in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1991 Oct; 259(1):330-6. PubMed ID: 1656027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of kappa-opiate receptor antagonist MR-2266-BS on ACTH and prolactin release].
    Xu RK; Chen L; Li H; Yang SJ; Huang XY
    Sheng Li Xue Bao; 1989 Aug; 41(4):395-401. PubMed ID: 2557673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strain differences in the analgesic and reinforcing action of morphine in mice.
    Semenova S; Kuzmin A; Zvartau E
    Pharmacol Biochem Behav; 1995 Jan; 50(1):17-21. PubMed ID: 7700949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay.
    Mogil JS; Kest B; Sadowski B; Belknap JK
    J Pharmacol Exp Ther; 1996 Feb; 276(2):532-44. PubMed ID: 8632319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperalgesia produced by intrathecal opioid antagonists depends on receptor selectivity and noxious stimulus.
    Pilcher CW; Browne JL
    NIDA Res Monogr; 1986; 75():469-72. PubMed ID: 2828994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kappa-opioid peptide receptor stimulation increases cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes.
    Ventura C; Capogrossi MC; Spurgeon HA; Lakatta EG
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1671-4. PubMed ID: 1659231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL; Richard JW; Thakur M
    Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strain differences in the magnitude of swimming-induced analgesia in mice correlate with brain opiate receptor concentration.
    Marek P; Yirmiya R; Liebeskind JC
    Brain Res; 1988 Apr; 447(1):188-90. PubMed ID: 2838128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.